Hussein A. Abbas - Concepedia

Author

Hussein A. Abbas

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

Abbas H., Abbas, Hussein, Abbas, Hussein A, Ferat Sahin, H A Abbas, H Abbas, H. A. Abbas, H. Abbas, H. Al-Saeed Abbas, H.A. Abbas

383

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center The University of Texas Health Science Center at Houston Baylor College of Medicine American University of Beirut Medical Center Albert Einstein College of Medicine

About

Hussein A. Abbas is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, cancer research, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	20	1.4K
2	Health Sciences	4	4	197
3	Public Health	2	2	33
4	Engineering	1	1	312
5	Nursing	1	1	20

Hussein A. Abbas

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance Yanshuo Chu, Enyu Dai, Yating Li, Nature Medicine Cancer ImmunosurveillanceT-regulatory CellImmunologyTumor ImmunityImmunoediting	2023	418
A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia Andy G.X. Zeng, Suraj Bansal, Liqing Jin, Nature Medicine Hematological MalignancyEngineeringTumor HeterogeneityMixed-phenotype Acute LeukemiaAcute Myeloid Leukemia	2022	312
Cross-species identification of genomic drivers of squamous cell carcinoma development across preneoplastic intermediates Vida Chitsazzadeh, Cristian Coarfa, Jennifer Drummond, Nature Communications	2016	153
Mdm2 Is Required for Survival of Hematopoietic Stem Cells/Progenitors via Dampening of ROS-Induced p53 Activity Hussein A. Abbas, Daniela R. Macció, Süleyman Coşkun, Cell stem cell Ros-induced P53 ActivityMedicineHematopoietic Stem Cells/progenitorsStem Cell MobilizationTumor Suppressor	2010	140
Single cell T cell landscape and T cell receptor repertoire profiling of AML in context of PD-1 blockade therapy Hussein A. Abbas, Dapeng Hao, Katarzyna Tomczak, Nature Communications	2021	128
The Prognostic and Therapeutic Role of Genomic Subtyping by Sequencing Tumor or Cell-Free DNA in Pulmonary Large-Cell Neuroendocrine Carcinoma Minglei Zhuo, Yanfang Guan, Xue Yang, Clinical Cancer Research	2019	94
Immune dysfunction signatures predict outcomes and define checkpoint blockade–unresponsive microenvironments in acute myeloid leukemia Sergio Rutella, Jayakumar Vadakekolathu, Francesco Mazziotta, Journal of Clinical Investigation	2022	90
The p53–Mdm2 feedback loop protects against DNA damage by inhibiting p53 activity but is dispensable for p53 stability, development, and longevity Vinod Pant, Shunbin Xiong, James G. Jackson, Genes & Development	2013	82
TRIM24 suppresses development of spontaneous hepatic lipid accumulation and hepatocellular carcinoma in mice Shiming Jiang, Lindsey Cauthen Minter, Sabrina A. Stratton, Journal of Hepatology HepatologyLiver PhysiologyPathologyHepatotoxicityLiver Disease	2014	75
Phase I/II Study of Azacitidine (AZA) with Venetoclax (VEN) and Magrolimab (Magro) in Patients (pts) with Newly Diagnosed Older/Unfit or High-Risk Acute Myeloid Leukemia (AML) and Relapsed/Refractory (R/R) AML Naval Daver, Marina Konopleva, Abhishek Maiti, Blood	2021	67

Page 1